Psoriasis and adverse pregnancy outcomes: a systematic review of observational studies. (1st September 2016)

• Record Type: Journal Article
• Authors: Bobotsis, R.; Gulliver, W.P.; Monaghan, K.; Lynde, C.; Fleming, P.
• Is Part Of: British journal of dermatology. Volume 175:Number 3(2016)
• Page Start: 464
• Page End: 472
• Publication Date: 2016-09-01
• Subjects: Dermatology -- Periodicals; Skin -- Diseases -- Periodicals; 616.5
• DOI: 10.1111/bjd.14547
• Languages: English
• ISSNs: 0007-0963

Abstract

Summary: Psoriasis is a chronic inflammatory disorder with significant physical and psychological sequelae. The majority of individuals experience disease onset in early adult life – for women this often occurs during their reproductive years. While some autoimmune diseases have been shown to affect pregnancy outcomes adversely, such a relationship has not been well studied in psoriasis. We searched PubMed, Embase and the Cochrane database for published articles examining psoriasis and adverse pregnancy outcomes, and included observational studies and clinical trials evaluating direct measures of maternal and fetal morbidity and mortality. Four of the nine included articles reported a statistically significant increase in the risk of at least one outcome, including spontaneous abortion, caesarean delivery, low birth weight, macrosomia, large‐for‐gestational age, and a composite outcome consisting of both prematurity and low birth weight. However, these associations were not always consistent across studies. Overall, there was no clear evidence of increased adverse outcomes in pregnant women with psoriasis.